Shineco, Inc. (TYHT) Stock Analysis

Shineco, Inc. (TYHT) Healthcare & Pipeline Overview

Shineco, Inc., based in Beijing, focuses on plant-based products across specialized textiles, herbal medicines, and organic agriculture. Operating through vertically-integrated channels, the company leverages indigenous Chinese plants and biotechnologies. Shineco faces challenges in a competitive healthcare market while pursuing growth in diverse product segments.

What Is the Investment Thesis for TYHT?

Shineco, Inc. presents a complex investment case. The company's diverse product portfolio, spanning textiles, herbal medicines, and agricultural products, offers potential revenue streams. However, the company's negative profit margin of -356.5% raises concerns about its financial sustainability. Growth catalysts include expanding its market presence in the health and well-being sector and leveraging its integrated production channels. Key risks involve navigating the competitive landscape of the healthcare and agricultural industries and achieving profitability. Investors should carefully assess Shineco's ability to improve its financial performance and capitalize on its growth opportunities.

Based on FMP financials and quantitative analysis

TYHT Key Highlights

Market capitalization of $229M indicates its size relative to other players in the drug manufacturing and specialty sectors.

• Negative P/E ratio of -0.00 reflects current losses and the absence of positive earnings.
• Profit margin of -356.5% signals significant challenges in achieving profitability.
• Gross margin of 7.6% suggests limited pricing power and high production costs.
• Beta of 1.85 indicates higher volatility compared to the broader market.

Who Are TYHT's Competitors?

TYHT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TYHT's Key Strengths?

Vertically integrated supply chain.

• Diverse product portfolio across textiles, herbal medicines, and agriculture.
• Expertise in utilizing indigenous Chinese plants.
• Established presence in the Chinese market.

What Are TYHT's Weaknesses?

Negative profit margin and financial losses.

• Limited brand recognition outside of China.
• High beta indicates higher volatility.
• Dependence on the Chinese market.

What Could Drive TYHT Stock Higher?

Potential partnerships with international distributors to expand market reach in 2027.

• Continued development and marketing of Bluish Dogbane (Luobuma) products.
• Expansion of organic agricultural product lines to meet growing demand.
• Efforts to improve financial performance and achieve profitability.

What Are the Key Risks for TYHT?

Financial-distress signal — its Altman Z-Score of -0.28 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-57.2%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Intense competition from established players in the healthcare and agricultural sectors.
• Regulatory changes and compliance requirements impacting the production and distribution of herbal medicines and agricultural products.
• Negative profit margin and financial losses impacting the company's sustainability.
• Supply chain disruptions affecting the availability of raw materials and finished goods.
• Economic downturns and market volatility impacting consumer demand for plant-based products.

What Are the Growth Opportunities for TYHT?

• Expansion of Herbal Product Line: Shineco has the opportunity to expand its herbal product line, tapping into the growing market for traditional Chinese medicine. The global herbal medicine market is projected to reach $147.1 billion by 2028, growing at a CAGR of 7.3%. By investing in research and development and expanding its distribution network, Shineco can increase its market share in this sector. Timeline: Ongoing.
• Increased Production of Organic Agricultural Products: There is a growing demand for organic agricultural products in China and internationally. Shineco can capitalize on this trend by increasing its production of organic produce and expanding its distribution channels. The global organic food market is projected to reach $323.19 billion by 2029. Timeline: Ongoing.
• Leveraging Bluish Dogbane (Luobuma) Products: Shineco can further develop and market specialized fabrics and textile products derived from Bluish Dogbane (Luobuma). This indigenous Chinese plant offers unique properties that can be leveraged in various applications, including health and wellness products. By focusing on research and development and marketing, Shineco can create a niche market for its Bluish Dogbane products. Timeline: Ongoing.
• Geographic Expansion: Shineco can expand its operations beyond China and target international markets with its plant-based products. By establishing partnerships with distributors and retailers in key markets, Shineco can increase its global reach and revenue. The global market for plant-based products is experiencing significant growth, presenting opportunities for Shineco to expand its international presence. Timeline: 2027-2028.
• Strategic Partnerships and Acquisitions: Shineco can pursue strategic partnerships and acquisitions to expand its product portfolio, distribution network, and technological capabilities. By partnering with other companies in the healthcare and agricultural sectors, Shineco can accelerate its growth and enhance its competitive position. This includes potential collaborations with research institutions to further innovate in herbal medicine and agricultural technology. Timeline: Ongoing.

What Are TYHT's Competitive Advantages?

• Vertically integrated production, distribution, and sales channels provide cost efficiencies and control over the supply chain.
• Proprietary knowledge and expertise in utilizing indigenous Chinese plants like Apocynum Venetum (Bluish Dogbane).
• Established relationships with suppliers and distributors in China.
• Focus on specialized and niche markets within the healthcare and agricultural sectors.

What Does TYHT Do?

Shineco, Inc., headquartered in Beijing, China, operates as a holding company with subsidiaries engaged in the production and distribution of plant-based products. The company provides health and well-being focused products through its vertically- and horizontally-integrated production, distribution, and sales channels. Shineco's operations are divided into three segments. The first involves developing, manufacturing, and distributing specialized fabrics, textile products, and by-products derived from Apocynum Venetum, also known as Bluish Dogbane (Luobuma). The second segment focuses on planting, processing, and distributing traditional Chinese medicinal herbal products and other pharmaceutical products. The third segment is dedicated to planting, processing, and distributing green and organic agricultural produce, as well as growing and cultivating Chinese Yew trees. Shineco employs engineering technologies and biotechnologies to produce Chinese herbal medicines, organic agricultural produce, and specialized textiles. The company aims to leverage its integrated approach to capitalize on the growing demand for plant-based products.

What Products and Services Does TYHT Offer?

• Develops specialized fabrics and textile products derived from Apocynum Venetum (Bluish Dogbane).
• Manufactures and distributes textile by-products.
• Plants, processes, and distributes traditional Chinese medicinal herbal products.
• Produces other pharmaceutical products.
• Plants, processes, and distributes green and organic agricultural produce.
• Grows and cultivates Chinese Yew trees.
• Utilizes engineering technologies and biotechnologies to produce herbal medicines, agricultural produce, and specialized textiles.

How Does TYHT Make Money?

• Vertically integrated production, distribution, and sales channels for plant-based products.
• Revenue generation through the sale of specialized textiles, herbal medicines, and organic agricultural produce.
• Leveraging indigenous Chinese plants and biotechnologies for product development.
• Focus on health and well-being focused plant-based products.

What Industry Does TYHT Operate In?

Shineco, Inc. operates within the healthcare sector, specifically in the drug manufacturers - specialty & generic industry. This industry is characterized by intense competition, regulatory scrutiny, and the need for continuous innovation. Market trends include increasing demand for plant-based products and traditional Chinese medicines. Shineco's integrated approach and focus on specialized textiles, herbal products, and agricultural produce differentiate it from some competitors. The company faces competition from both established pharmaceutical companies and smaller, specialized manufacturers.

Who Are TYHT's Key Customers?

• Consumers seeking health and well-being focused plant-based products.
• Textile manufacturers utilizing specialized fabrics.
• Pharmaceutical companies incorporating herbal medicines.
• Retailers and distributors of organic agricultural produce.

Shineco, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.28 places it in the distress zone, a signal of elevated financial risk.

TYHT Valuation & Market Position

With a $229M market cap, Shineco, Inc. sits in the micro-cap segment of the market.

Return on equity for Shineco, Inc. stands at -57.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -51.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -6.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.33 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -64.4%, the inverse of the P/E and a quick read on earnings relative to price.

Company Profile

Shineco, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Beijing, CN. The company is led by CEO Yuying Zhang. TYHT has traded publicly since 2016.

TYHT Financials

TYHT Latest News

No recent news available for TYHT.

Shineco, Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources